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We have developed a targeted UHPLC-ESI–MS/MS method for the quantification of kynurenic 
acid (KYNA) and its derivatives from biological samples. The samples were gained from in 
vitro permeability assay. We have found that the transportation of the derivatives through the 
blood-brain barrier is better than KYNA.  
Introduction  
Since kynurenic pathway has a great influence on the central nervous system, interruption of 
its chemical balance could lead to the development of neurodegenerative diseases. The 
kynurenics that have positive effect can get through the blood-brain barrier only in a very 
minimal rate, so restoring the balance is difficult. Nowadays best possible therapy seems to be 
the use of derivatives of KYNA as active ingredient. 
Experimental 
The method development and its application was preceded by an in vitro permeability assay 
using primary rat brain endothelial cells. The level of KYNA and its derivatives (SZR104, 
SZR72) that has passed through the assay was determined by a targeted ultra-high performance 
liquid chromatography combined with electrospray ionisation triple quadrupole tandem mass 
spectrometry (UHPLC-ESI-MS/MS) method. For quantitative analysis, external calibration 
was applied using SZR73 as an internal standard. 
Results and discussion 
The main parameters of the sample preparation and the targeted UHPLC-ESI-MS/MS method 
were optimized. The developed procedures were successfully applied for quantification of 
KYNA, SZR104 and SZR72 in the biological samples. Overall, the derivatives have 
significantly better transportation through the blood-brain barrier than the KYNA. The amount 
of the transferred compounds was the following in descending order: SZR104, SZR72 and 
KYNA. 
  




Figure 1. The amount of transferred chemicals in vitro permeability assay 
Conclusion  
Using the developed method on the biological samples, we have found that the amount of 
transported kynurenics is linked to the duration of the assay and the chemical modification of 
KYNA improved the permeability. 
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